NCT03154814View on ClinicalTrials.gov

Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

April 1, 2017

Study Completion Date

May 1, 2017

Conditions
Cardiopulmonary BypassCardiac Surgery
Interventions
DRUG

ulinastatin

ulinastatin (10000 U/kg and 5000 U/kg/h) was administered during CPB

DRUG

control

conventional CPB was applied without ulinastatin treatment

Trial Locations (2)

133-798

Konkuk University Medical Center, Seoul

143-729

Konkuk University Medical Center, Seoul

All Listed Sponsors
lead

Konkuk University Medical Center

OTHER

NCT03154814 - Ulinastatin Improves Postoperative Oxygenation After Cardiopulmonary Bypass | Biotech Hunter | Biotech Hunter